Encouraging results for Immutep’s cancer therapies
![](https://www.sharecafe.com.au/wp-content/uploads/2024/03/fnn-458866.jpg)
Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck cancer, lung cancer and breast cancer.
Read More